
    
      Sixty adolescents, ages 13-19 years, with type 1 diabetes and an HbA1c > = 8 % who are also
      naive to CGMS use will be recruited from the diabetes outpatient population followed at
      Bellevue Hospital, Lutheran Hospital, Woodhull Hospital, and the NYU Fink Pediatric
      Ambulatory Care Center. Forty subjects will be randomly assigned to the CGMS group and 20
      subjects will be assigned to the control group.
    
  